CEO Total Pay
$191K
FY2021 Summary Compensation, below median
URGN FY2021 SEC EDGAR DEF 14A
UroGen Pharma Ltd. CEO pay ratio
The CEO earned $191K in FY2021 against median worker pay of $191,462 · Chemicals & Pharmaceuticals.
- State
- L3
- Filing date
- 2022-05-02
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2021
Data updated August 2026
Subscribe to UroGen Pharma Ltd. CEO pay filing updates (RSS)
CEO-to-worker pay ratio
23:1
Below Average (Scale: 0–1000:1)
CEO pay
$191K
Median worker
$191,462
Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
UroGen Pharma Ltd. reported a 23:1 CEO-to-worker pay ratio in FY2021 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 23:1
- FY2021 disclosed
- CEO total
- $191K
- Summary Compensation Table total
- Median worker
- $191,462
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2021
A component-level pay breakdown is not reported in UroGen Pharma Ltd.'s structured SEC pay-ratio disclosure. See our methodology →
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
23:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$191K
Companies in Industry
168
vs. Industry Median
Below
UroGen Pharma Ltd.: near-parity Item 402(u) ratio
UroGen Pharma Ltd. stamps FLOOR · ELITE-MED at 23:1 against $191,462 median worker pay in FY2021. the CEO earned 23× the median employee ($191,462) in FY2021.
At $191,462 median worker pay, the FLOOR stamp is near pay-parity territory under MICRO CEO total.
Pay Ratio
23:1
Below typical
What FY2021 shows for UroGen Pharma Ltd.
UroGen Pharma Ltd. stamps FLOOR · ELITE-MED at 23:1 against $191,462 median worker pay in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; UroGen Pharma Ltd.'s $191K CEO total is at or below the $7.9M industry median CEO pay.
UroGen Pharma Ltd. stamps FLOOR · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2021
- Total Compensation
- $191K
- Median Employee Pay
- $191,462
- Pay Ratio
- 23:1
- Filing Date
- 2022-05-02
Company Info
- Ticker
- URGN
- CIK
- 1668243
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- L3
SEC EDGAR DEF 14A for CIK 1668243, FY2021. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. UroGen Pharma Ltd. stamps FLOOR · ELITE-MED at 23:1 against $191,462 median worker pay in FY2021.
Read with UroGen Pharma Ltd.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MICRO · ELITE-MED.
Arista Networks, Inc. · MICRO
ABS(ceo_total_comp) peer at $191K (Δ $646 lighter vs UroGen Pharma Ltd.); MID · ELITE-MED vs this page's FLOOR · MICRO · ELITE-MED.
Trex Co Inc · MICRO
ABS(ceo_total_comp) peer at $190K (Δ $1K lighter vs UroGen Pharma Ltd.); FLOOR · PAR-MED vs this page's FLOOR · MICRO · ELITE-MED.
Nektar Therapeutics · MICRO
ABS(ceo_total_comp) peer at $194K (Δ $2K heavier vs UroGen Pharma Ltd.); MODEST · ELITE-MED vs this page's FLOOR · MICRO · ELITE-MED.
Amedisys Inc · MICRO
ABS(ceo_total_comp) peer at $194K (Δ $2K heavier vs UroGen Pharma Ltd.); FLOOR · PAR-MED vs this page's FLOOR · MICRO · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
UroGen Pharma Ltd. stamps FLOOR · MICRO · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · FLOOR
See where FLOOR · MICRO packages sit on the national leaderboard after reading UroGen Pharma Ltd..
Ratio primer · FLOOR
UroGen Pharma Ltd.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for UroGen Pharma Ltd. (CIK 1668243), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.